The new company will be named Life Technologies Corporation and will be traded on the NASDAQ global select market under the ticker symbol ‘LIFE’ beginning November 24, 2008.
Greg Lucier, chairman and CEO of Life Technologies, said: “This is an exciting time in the history of Invitrogen and Applied Biosystems. By combining these two highly respected brands, we are not only creating a stronger company, but an industry thought leader, uniquely positioned to help our customers accelerate and drive new discoveries and commercial applications.
“On behalf of the new management team, I want to welcome all employees to our new company. I am confident that together we will change the future of life science.”